Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Oblimersen

Next Previous
X
Search
Drug Profile

Oblimersen

Alternative Names: Augmerosen; BCL-2 antisense oligonucleotide - Genta; G 3139; GC 3139; Genasense; Oblimersen sodium

Latest Information Update: 15 Jan 2022

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Pennsylvania
  • Developer Genta; Genta (CEASED); National Cancer Institute (USA)
  • Class Antineoplastics; Antisense oligonucleotides; Thionucleotides
  • Mechanism of Action Proto-oncogene protein c-bcl-2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Multiple myeloma; Malignant melanoma; Chronic lymphocytic leukaemia; Acute myeloid leukaemia
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Acute myeloid leukaemia; Breast cancer; Chronic lymphocytic leukaemia; Liver cancer; Malignant melanoma; Non-Hodgkin's lymphoma; Non-small cell lung cancer; Prostate cancer; Solid tumours

Most Recent Events

  • 31 Dec 2011 Discontinued - Phase-I for Solid tumours in USA (SC)
  • 31 Dec 2011 Discontinued - Phase-I/II for Solid tumours in USA (IV)
  • 31 Dec 2011 Discontinued - Phase-II for Breast cancer in USA (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top